We use cookies to improve your experience. See our Privacy Policy.
Exelixis, Inc.. is a biological products, (no diagnostic substances) company incorporated in DE, trading on the Nasdaq.
Exchange
Nasdaq
Sector
Healthcare
Filer Category
Large accelerated filer
Fiscal Year End
January
Exelixis, Inc.. is a biological products, (no diagnostic substances) company incorporated in DE, trading on the Nasdaq.
No SEC filings have been processed for EXEL yet. Filings will be analyzed automatically when the EDGAR pipeline next runs.
No recent insider transactions have been detected in EXEL SEC filings.
Exelixis, Inc.. is incorporated in DE and is classified as a Large accelerated filer filer with the SEC.
Exelixis, Inc..'s fiscal year ends in January. Annual 10-K reports are typically filed within 60-90 days after the fiscal year end.
Data sourced from SEC EDGAR public filings. For informational purposes only — not investment advice. AI-generated summaries may contain errors. See our full disclaimer.